Boston Scientific mulls sale of cardiac, vascular surgery businesses

Interventional device developer Boston Scientific plans to explore the sale of its cardiac surgery and vascular surgery businesses, the Natick, MA-based firm reported. The move is part of the company's plan to streamline its portfolio and strengthen its operating and financial performance.

Boston Scientific acquired the cardiac surgery business in April of last year as part of its deal with Guidant. The business develops medical technologies to provide less-invasive therapies in cardiac surgery.

Its vascular surgery business was acquired in 1995 as part of its purchase of Meadox Medicals; it develops synthetic grafts and patches for the repair of abdominal aortic aneurysms and peripheral vascular anatomy.

By staff writers
August 16, 2007

Related Reading

Boston Scientific to keep Endosurgery unit, August 3, 2007

Boston Scientific begins Taxus Element stent trial, July 20, 2007

Boston Scientific brings Taxus Express² to Japan, May 8, 2007

Boston Scientific gets Japanese nod for Taxus, April 3, 2007

Boston Scientific shows year-end, Q4 sales growth, February 1, 2007

Copyright © 2007

Page 1 of 374
Next Page